LARS2-SEC22A Fusion FISH Probe
The LARS2-SEC22A Fusion FISH Probe is used to confirm a fusion of the LARS2 and SEC22A genes. The fusion of the LARS2 and SEC22A genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| LARS2-SEC22A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| LARS2-SEC22A-20-AQAQ | 20 (40 μL) | 200 μL |
|
LARS2 Gene Summary
This gene encodes a class 1 aminoacyl-tRNA synthetase, mitochondrial leucyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. [provided by RefSeq, Jul 2008]
Gene Name: Leucyl-tRNA Synthetase 2, Mitochondrial
Chromosome: CHR3: 45430074 -45590328
Locus: 3p21.31
SEC22A Gene Summary
The protein encoded by this gene belongs to the member of the SEC22 family of vesicle trafficking proteins. This protein has similarity to rat SEC22 and may act in the early stages of the secretory pathway. [provided by RefSeq, Nov 2008]
Gene Name: SEC22 Homolog A, Vesicle Trafficking Protein
Chromosome: CHR3: 122920773 -122992982
Locus: 3q21.1
Gene Diseases
The LARS2 SEC22A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|